ArticleThe New England journal of medicine2015
Ezetimibe plus a Statin after Acute Coronary Syndromes.
Article in The New England journal of medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Trial
- Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis.Communications biology · 2025Article
- Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.Journal of lipid and atherosclerosis · 2025Review
- The Evaluation and Management of Coronary Artery Disease in the Lung Transplant Patient.Journal of clinical medicine · 2023Review
- PCSK9 Biology and Its Role in Atherothrombosis.International journal of molecular sciences · 2021Review
- Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art.Journal of clinical medicine · 2021Review
- Cardiovascular Risk in Type 1 Diabetes Mellitus.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019Review
- Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy.Cardiovascular therapeutics · 2019Observational
- Trials and Tribulations of CETP Inhibitors.Circulation research · 2018Review
- Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.PloS one · 2018Article
- Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans.Arteriosclerosis, thrombosis, and vascular biology · 2017Article
- Cholesterol trials and mortality.British journal of clinical pharmacology · 2016Article
- Interventions for Extracranial Carotid Artery Stenosis: An Update.Current treatment options in cardiovascular medicine · 2016Review
- Retargeting the management of hypercholesterolemia - focus on evolocumab.Therapeutics and clinical risk management · 2016Review
Corrections and comments
- Comment on
- Comment on
- Comment on
- Comment on
- Comment on
- Comment on
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26444734What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.